---
id: aasld-cirrhosis-management-2024
title: "AASLD 2024 Practice Guidance: Management of Complications of Cirrhosis"
short_title: "AASLD Cirrhosis Complications 2024"

organization: American Association for the Study of Liver Diseases
collaborators: null
country: US
url: https://www.aasld.org/practice-guidelines
doi: null
pmid: null
open_access: true

specialty: hepatology
guideline_type: clinical-practice
evidence_system: AASLD
conditions:
  - cirrhosis
  - ascites
  - hepatic encephalopathy
  - variceal bleeding
  - SBP
tags:
  - diuretics
  - lactulose
  - rifaximin
  - paracentesis
  - TIPS

publication_date: 2024-08-01
previous_version_date: 2021-08-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 AASLD practice guidance on the management of cirrhosis complications: ascites, hepatic encephalopathy, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome.

## Key Recommendations

### Ascites

#### Initial Evaluation
- Diagnostic paracentesis for new-onset ascites or hospitalized cirrhotic patients with ascites. SAAG ≥1.1 confirms portal hypertension.

#### Management
- **Sodium Restriction**: <2 g/day.
- **Diuretics**: Spironolactone (starting 100 mg/day) ± furosemide (40 mg/day). Titrate to achieve 0.5-1 kg/day weight loss.
- **Large Volume Paracentesis (LVP)**: For tense/refractory ascites. Give albumin (6-8 g/L of ascites removed) if >5 L removed.
- **TIPS**: For diuretic-refractory ascites in appropriate candidates.

### Spontaneous Bacterial Peritonitis (SBP)
- PMN ≥250 cells/mm³ in ascitic fluid = SBP.
- **Empiric Antibiotics**: Ceftriaxone 2 g IV daily x 5-7 days (or fluoroquinolone if allergic); narrow based on culture.
- **Albumin**: 1.5 g/kg on day 1, 1 g/kg on day 3 (reduces renal failure and mortality).
- **Prophylaxis**: Norfloxacin or TMP-SMX for prior SBP, low ascitic protein (<1.5 g/dL + renal dysfunction or high bilirubin/low sodium), or GI bleed.

### Hepatic Encephalopathy (HE)
- Precipitants: Infection, GI bleed, constipation, medications, dehydration, electrolyte disturbance.
- **Lactulose**: Titrate to 2-3 soft stools/day. First-line.
- **Rifaximin**: Add for recurrent HE despite lactulose.
- Protein restriction is NOT recommended.

### Hepatorenal Syndrome (HRS-AKI)
- Exclude other causes of AKI, volume challenge with albumin (1 g/kg/day x 2 days).
- **Terlipressin + Albumin**: FDA-approved for HRS-AKI. Improves renal function.
- **Alternative**: Norepinephrine + albumin (ICU).
- **Liver Transplant**: Definitive treatment.
